Bradford C. Connett Sells 4,036 Shares of Henry Schein, Inc. (NASDAQ:HSIC) Stock

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Henry Schein Trading Up 2.0 %

Shares of Henry Schein stock traded up $1.37 during trading hours on Monday, hitting $70.76. The company's stock had a trading volume of 779,046 shares, compared to its average volume of 1,508,752. The company has a market capitalization of $8.79 billion, a PE ratio of 29.12, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a 50 day moving average of $74.82 and a 200 day moving average of $72.64. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.66 earnings per share. Analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Remove Ads

Analysts Set New Price Targets

A number of research analysts have commented on the company. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective for the company. Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. UBS Group cut their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and a consensus price target of $81.10.

Institutional Investors Weigh In On Henry Schein

A number of large investors have recently bought and sold shares of HSIC. Versant Capital Management Inc boosted its stake in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares in the last quarter. Investment Management Corp VA ADV acquired a new position in Henry Schein in the 4th quarter worth about $32,000. Venturi Wealth Management LLC increased its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after buying an additional 569 shares during the period. Quent Capital LLC boosted its position in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after buying an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC boosted its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.